Virtu Financial’s Dogwood Therapeutics DWTX Stock Holding History

Virtu Financial’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-474	Closed	-$3K	–	1983
2024 Q2	$3K	Buy	+474	New	+$4.1K	﹤0.01%	1199
2023 Q4	–	Sell	-1,093	Closed	-$25K	–	2094
2023 Q3	$25K	Buy	+1,093	New	+$38K	﹤0.01%	980
2023 Q1	–	Sell	-671	Closed	-$4K	–	2193
2022 Q4	$4K	Sell	671 -1,240	-65%	-$9.34K	﹤0.01%	1461
2022 Q3	$18K	Buy	+1,911	New	+$269K	﹤0.01%	1426
2021 Q3	–	Sell	-524	Closed	-$82K	–	2054
2021 Q2	$82K	Buy	+524	New	+$74.3K	0.01%	1247
2021 Q1	–	Sell	-1,409	Closed	-$264K	–	2111
2020 Q4	$264K	Buy	+1,409	New	+$340K	0.03%	699

Other funds holding DWTX

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's DWTX Position: Q3 2024 in Review

Virtu Financial sold out of Dogwood Therapeutics (DWTX) in Q3 2024, closing a stake of 474 shares — an estimated $3K sold.

Virtu Financial first reported a position in DWTX in Q4 2020 and held it in 6 quarters. The position peaked at $264K in Q4 2020. 24 funds tracked by Wall St. Rank hold DWTX as of Q3 2024.

Virtu Financial reported no remaining Dogwood Therapeutics position as of Q3 2024 after selling out during the quarter.
Virtu Financial sold 474 Dogwood Therapeutics shares in Q3 2024, an estimated $3K.
Virtu Financial first reported a position in Dogwood Therapeutics in Q4 2020 and held it in 6 quarters.
Virtu Financial's Dogwood Therapeutics position peaked at $264K in Q4 2020.
24 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.